Published in Rheumatology (Oxford) on July 22, 2010
Developing standards of care for patients with juvenile idiopathic arthritis. Rheumatology (Oxford) (2010) 1.51
Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. Magn Reson Med (2006) 3.63
Health and disease in 85 year olds: baseline findings from the Newcastle 85+ cohort study. BMJ (2009) 3.20
BSPAR Standards of Care for children and young people with juvenile idiopathic arthritis. Rheumatology (Oxford) (2010) 2.68
Functional reactivity of cerebral capillaries. J Cereb Blood Flow Metab (2007) 2.10
Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature. Nat Genet (2011) 1.84
Frailty and the role of inflammation, immunosenescence and cellular ageing in the very old: cross-sectional findings from the Newcastle 85+ Study. Mech Ageing Dev (2012) 1.67
Reflex sympathetic dystrophy: a multidisciplinary approach. Arthritis Rheum (2004) 1.62
Quantifying antivascular effects of monoclonal antibodies to vascular endothelial growth factor: insights from imaging. Clin Cancer Res (2009) 1.56
ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency. Brain (2007) 1.55
Antihypertensive drug use and risk of cognitive decline in the very old: an observational study - The Newcastle 85+ Study. J Hypertens (2015) 1.43
The impact of a coordinated transitional care programme on adolescents with juvenile idiopathic arthritis. Rheumatology (Oxford) (2006) 1.40
Old challenges and new directions in pediatric rheumatology. J Rheumatol (2006) 1.40
Assessment of a large panel of candidate biomarkers of ageing in the Newcastle 85+ study. Mech Ageing Dev (2011) 1.36
Disease activity and disability in children with juvenile idiopathic arthritis one year following presentation to paediatric rheumatology. Results from the Childhood Arthritis Prospective Study. Rheumatology (Oxford) (2009) 1.30
Phase I evaluation of a fully human anti-alphav integrin monoclonal antibody (CNTO 95) in patients with advanced solid tumors. Clin Cancer Res (2007) 1.27
Communication about children's clinical trials as observed and experienced: qualitative study of parents and practitioners. PLoS One (2011) 1.25
Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1. Am J Med Genet A (2015) 1.17
Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis patients. Rheumatology (Oxford) (2010) 1.13
Young people's satisfaction of transitional care in adolescent rheumatology in the UK. Child Care Health Dev (2007) 1.12
Doctors likely to encounter children with musculoskeletal complaints have low confidence in their clinical skills. J Pediatr (2008) 1.11
Development and preliminary validation of the 'Mind the Gap' scale to assess satisfaction with transitional health care among adolescents with juvenile idiopathic arthritis. Child Care Health Dev (2007) 1.05
Growing up and moving on. A multicentre UK audit of the transfer of adolescents with juvenile idiopathic arthritis from paediatric to adult centred care. Ann Rheum Dis (2005) 1.02
The role of neutrophil apoptosis in juvenile-onset systemic lupus erythematosus. Arthritis Rheum (2009) 1.02
Comparison of the performance of tracer kinetic model-driven registration for dynamic contrast enhanced MRI using different models of contrast enhancement. Acad Radiol (2006) 1.01
Validity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic arthritis. Ann Rheum Dis (2012) 1.01
International consensus for provisions of quality-driven care in childhood-onset systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2013) 1.00
Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort. Arthritis Rheum (2012) 1.00
Agreement between proxy and adolescent assessment of disability, pain, and well-being in juvenile idiopathic arthritis. J Pediatr (2011) 1.00
Wnt-1-inducible signaling pathway protein 3 and susceptibility to juvenile idiopathic arthritis. Arthritis Rheum (2005) 0.99
Tracer kinetic model-driven registration for dynamic contrast-enhanced MRI time-series data. Magn Reson Med (2007) 0.99
Losing the ability in activities of daily living in the oldest old: a hierarchic disability scale from the Newcastle 85+ study. PLoS One (2012) 0.97
Capability and dependency in the Newcastle 85+ cohort study. Projections of future care needs. BMC Geriatr (2011) 0.97
Growing up and moving on in rheumatology: a multicentre cohort of adolescents with juvenile idiopathic arthritis. Rheumatology (Oxford) (2005) 0.97
Fecal calprotectin and lactoferrin as noninvasive markers of pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr (2009) 0.95
Biologic treatment response among adults with juvenile idiopathic arthritis: results from the British Society for Rheumatology Biologics Register. Rheumatology (Oxford) (2013) 0.94
Utility of NT-proBNP as a rule-out test for left ventricular dysfunction in very old people with limiting dyspnoea: the Newcastle 85+ Study. BMC Cardiovasc Disord (2014) 0.93
Chronic neurological deficits in mice after perinatal hypoxia and ischemia correlate with hemispheric tissue loss and white matter injury detected by MRI. Dev Neurosci (2011) 0.92
The impact of visual impairment on Mini-Mental State Examination Scores in the Newcastle 85+ study. Age Ageing (2012) 0.92
Positive association of SLC26A2 gene polymorphisms with susceptibility to systemic-onset juvenile idiopathic arthritis. Arthritis Rheum (2007) 0.91
Chronic recurrent multifocal osteomyelitis mimicked in childhood hypophosphatasia. J Bone Miner Res (2009) 0.91
A magnetic resonance spectroscopy study of brain glutamate in a model of plasticity in human pharyngeal motor cortex. Gastroenterology (2008) 0.91
Cardiovascular risk in juvenile idiopathic arthritis. Rheumatology (Oxford) (2013) 0.91
Paediatric rheumatology practice in the UK benchmarked against the British Society for Paediatric and Adolescent Rheumatology/Arthritis and Musculoskeletal Alliance Standards of Care for juvenile idiopathic arthritis. Rheumatology (Oxford) (2013) 0.90
The development and assessment of biological treatments for children. Br J Clin Pharmacol (2015) 0.89
Standard 5: selection, measurement, and reporting of outcomes in clinical trials in children. Pediatrics (2012) 0.89
Assessment of sleep and circadian rhythm disorders in the very old: the Newcastle 85+ Cohort Study. Age Ageing (2013) 0.88
The relationships between adult juvenile idiopathic arthritis and employment. Arthritis Rheum (2012) 0.88
Influence of childhood scleroderma on physical function and quality of life. J Rheumatol (2010) 0.88
The personal and health service impact of falls in 85 year olds: cross-sectional findings from the Newcastle 85+ cohort study. PLoS One (2012) 0.88
Urine biomarkers in juvenile-onset SLE nephritis. Pediatr Nephrol (2012) 0.88
Needle-free and microneedle drug delivery in children: a case for disease-modifying antirheumatic drugs (DMARDs). Int J Pharm (2011) 0.86
Paternal imprints can be established on the maternal Igf2-H19 locus without altering replication timing of DNA. Hum Mol Genet (2003) 0.86
Craniofacial growth in fetal Tarsius bancanus: brains, eyes and nasal septa. J Anat (2007) 0.84
Macrophage activation syndrome is hemophagocytic lymphohistiocytosis--need for the right terminology. J Rheumatol (2002) 0.84
A randomized comparative trial of generalized vs targeted physiotherapy in the management of childhood hypermobility. Rheumatology (Oxford) (2009) 0.84
Preliminary criteria for global flares in childhood-onset systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2011) 0.84
Incidence of childhood linear scleroderma and systemic sclerosis in the UK and Ireland. Arthritis Care Res (Hoboken) (2010) 0.83
Henoch schonlein purpura--a 5-year review and proposed pathway. PLoS One (2012) 0.83
Prevalence of left ventricular dysfunction in a UK community sample of very old people: the Newcastle 85+ study. Heart (2012) 0.83
Bone health in adult men and women with a history of juvenile idiopathic arthritis. J Rheumatol (2011) 0.83
Frailty and mortality are not influenced by mitochondrial DNA haplotypes in the very old. Neurobiol Aging (2013) 0.82
The association between low socioeconomic status with high physical limitations and low illness self-perception in patients with juvenile idiopathic arthritis: results from the Childhood Arthritis Prospective Study. Arthritis Care Res (Hoboken) (2015) 0.82
Prevalence of arthritis and joint pain in the oldest old: findings from the Newcastle 85+ study. Age Ageing (2011) 0.82
Clinical features of childhood localized scleroderma in an incidence cohort. Rheumatology (Oxford) (2011) 0.81
[Medical education seemingly "immune" to discussions on sex and gender. A study indicates that the gender perspective in teaching is limited]. Lakartidningen (2003) 0.81
Can protein contamination be removed from hand endodontic instruments? Prim Dent Care (2009) 0.81
Expression of Toll-like receptors and their detection of nuclear self-antigen leading to immune activation in JSLE. Rheumatology (Oxford) (2012) 0.81
Urine biomarkers for monitoring juvenile lupus nephritis: a prospective longitudinal study. Pediatr Nephrol (2013) 0.81
Long term outcome following knee replacement in patients with juvenile idiopathic arthritis. Knee (2009) 0.81
NIHR Medicines for Children Research Network: improving children's health through clinical research. Expert Rev Clin Pharmacol (2013) 0.80
The association between diagnosed glaucoma and cataract and cognitive performance in very old people: cross-sectional findings from the newcastle 85+ study. Ophthalmic Epidemiol (2013) 0.80
Recurrent hemiplegia associated with cerebral vasculopathy following third trimester maternal herpes zoster infection. Dev Med Child Neurol (2006) 0.80
Autologous T cell depleted haematopoietic stem cell transplantation in children with severe juvenile idiopathic arthritis in the UK (2000-2007). Mol Immunol (2009) 0.80
Septic arthritis of the pubic symphysis in an 11-year-old boy. Pediatr Emerg Care (2009) 0.80
Is there an association between metabolic syndrome and cognitive function in very old adults? The Newcastle 85+ Study. J Am Geriatr Soc (2015) 0.80
Recent developments in disease activity indices and outcome measures for juvenile idiopathic arthritis. Rheumatology (Oxford) (2013) 0.79
Acquisition of aberrant DNA methylation is associated with frailty in the very old: findings from the Newcastle 85+ Study. Biogerontology (2014) 0.79
Inactive disease and remission in childhood-onset systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2012) 0.79
Magnetic resonance spectroscopy in vivo of neurochemicals in a transgenic model of Alzheimer's disease: a longitudinal study of metabolites, relaxation time, and behavioral analysis in TASTPM and wild-type mice. Magn Reson Med (2012) 0.79
Delivery of paediatric rheumatology care in the UK--the projected shortfall. Clin Rheumatol (2010) 0.78
Association of glutathione-S-transferase-P1 (GSTP1) polymorphism 105 Ile>val with chronic lung disease in preterm infants. J Perinatol (2004) 0.78
Immunological characteristics and T-cell receptor clonal diversity in children with systemic juvenile idiopathic arthritis undergoing T-cell-depleted autologous stem cell transplantation. Immunology (2014) 0.78
Adding to complexity: comorbidity in paediatric rheumatic disease. Rheumatology (Oxford) (2012) 0.77
The protective effect of GM-CSF on serum-induced neutrophil apoptosis in juvenile systemic lupus erythematosus patients. Clin Rheumatol (2014) 0.77
Homo-oligomerization of the activating natural killer cell receptor NKp30 ectodomain increases its binding affinity for cellular ligands. J Biol Chem (2013) 0.77
Occurrence of Raynaud's phenomenon in children ages 12-15 years: prevalence and association with other common symptoms. Arthritis Rheum (2003) 0.77
Paediatric use of mycophenolate mofetil. Br J Clin Pharmacol (2013) 0.77
Predictors of access to care in juvenile systemic lupus erythematosus: evidence from the UK JSLE Cohort Study. Rheumatology (Oxford) (2013) 0.76
The pro-inflammatory potential of T cells in juvenile-onset systemic lupus erythematosus. Pediatr Rheumatol Online J (2014) 0.76